68 related articles for article (PubMed ID: 15631652)
1. [Identification bcr-abl fusion gene in leukemia cells with oligonucleotide microarray].
Li Y; Huang J; Chen JP; Liang HJ; Wang SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):743-7. PubMed ID: 15631652
[TBL] [Abstract][Full Text] [Related]
2. Nuclear topography and expression of the BCR/ABL fusion gene and its protein level influenced by cell differentiation and RNA interference.
Bártová E; Harnicarová A; Pacherník J; Kozubek S
Leuk Res; 2005 Aug; 29(8):901-13. PubMed ID: 15978941
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of dual color-dual fusion translocation fluorescence in situ hybridization in the detection of bcr/abl fusion gene.
Wu B; Zhou S; Song L; Liu X
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):364-6. PubMed ID: 12408765
[TBL] [Abstract][Full Text] [Related]
4. [Detection of bcr-abl fusion gene mRNA level in K562/A02 cell line by real-time quantitative RT-PCR].
Chen BA; Zhou GN; Cheng J; Qiao C; Wu YJ; Li JY; Ding JH; Gao C; Zhao G; Wang J; Bao W; Song HH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):40-3. PubMed ID: 21362218
[TBL] [Abstract][Full Text] [Related]
5. Identification of leukemia-specific fusion gene transcripts with a novel oligonucleotide array.
Chun SM; Kim YL; Choi HB; Oh YT; Kim YJ; Lee S; Kim TG; Yang EG; Park YK; Kim DW; Han BD
Mol Diagn Ther; 2007; 11(1):21-8. PubMed ID: 17286448
[TBL] [Abstract][Full Text] [Related]
6. [Detection and quantification of aberrant leukemia fusion gene by real-time RT-PCR].
Li XJ; Yu MJ; Liang Y; He D; Li B; Hu J; Chen Q; Li HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):969-73. PubMed ID: 19698240
[TBL] [Abstract][Full Text] [Related]
7. [Effects of specific siRNA targeting at bcr-abl fusion gene and its combination with p27 gene clone on chronic myeloid leukemia cell line K562].
Wang W; DU Y; Lin GQ; Li NN; Sun BZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):606-11. PubMed ID: 20561411
[TBL] [Abstract][Full Text] [Related]
8. [Detection of BCR/ABL fusion gene by fluorescence in situ hybridization and its clinical application].
Zhou RL; Mo YX; Lan M; Lin JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1283-8. PubMed ID: 22040989
[TBL] [Abstract][Full Text] [Related]
9. [Effect of tetrandrine combined with Droloxifen on the expression of bcr/abl of K562 at both mRNA and protein levels].
Chen BA; Qian XJ; Cheng J; Gao F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):95-9. PubMed ID: 15748444
[TBL] [Abstract][Full Text] [Related]
10. Imatinib inhibits the expression of SCO2 and FRATAXIN genes that encode mitochondrial proteins in human Bcr-Abl⁺ leukemia cells.
Papadopoulou LC; Kyriazou AV; Bonovolias ID; Tsiftsoglou AS
Blood Cells Mol Dis; 2014; 53(1-2):84-90. PubMed ID: 24726617
[TBL] [Abstract][Full Text] [Related]
11. [Construction of genetically modified dendritic cell vaccine expressing bcr/abl fusion gene and inducing specific cytotoxic T lymphocytes to kill K562 cells in vitro].
Wang WW; Huang RW; Hu Y; Li XD; Wang DN; He Y; Liu JJ
Ai Zheng; 2009 Jun; 28(6):602-6. PubMed ID: 19635197
[TBL] [Abstract][Full Text] [Related]
12. Purification of TAT-CC-HA protein under native condition, and its transduction analysis and biological effects on BCR-ABL positive cells.
Huang Z; Ji M; Peng Z; Huang S; Xiao Q; Li C; Zeng J; Gao M; Feng W
Biomed Pharmacother; 2011 Jun; 65(3):183-92. PubMed ID: 21641753
[TBL] [Abstract][Full Text] [Related]
13. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].
Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468
[TBL] [Abstract][Full Text] [Related]
14. [Effect of dihydroartemisinin on the expression of BCR/ABL fusion gene in leukemia K562 cells].
Gao JL; Ding XP; Li QJ; Xia ZL; Xia QJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Feb; 29(1):19-22. PubMed ID: 22311485
[TBL] [Abstract][Full Text] [Related]
15. Genotyping of chimerical BCR-ABL1 RNA in chronic myeloid leukemia by integrated DNA chip.
Kang JH; Goh HG; Chae SH; Kim SY; Kim DW; Chae CB
J Mol Diagn; 2012 Sep; 14(5):487-93. PubMed ID: 22749885
[TBL] [Abstract][Full Text] [Related]
16. Detection of molecular variants of BCR-ABL gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR).
Udomsakdi-Auewarakul C; U-Pratya Y; Boonmoh S; Vatanavicharn S
J Med Assoc Thai; 2000 Aug; 83(8):928-35. PubMed ID: 10998848
[TBL] [Abstract][Full Text] [Related]
17. Multiplex in-cell reverse transcription-polymerase chain reaction for the simultaneous detection of p210 and p190 BCR-ABL mRNAs in chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia cell lines.
Suh SP; Kee SJ; Lim WH; Song JW; Lee SK; Kim JP; Shin JH; Ryang DW
Clin Chem Lab Med; 2000 Sep; 38(9):939-44. PubMed ID: 11097354
[TBL] [Abstract][Full Text] [Related]
18. Gallic acid downregulates matrix metalloproteinase-2 (MMP-2) and MMP-9 in human leukemia cells with expressed Bcr/Abl.
Chen YJ; Chang LS
Mol Nutr Food Res; 2012 Sep; 56(9):1398-412. PubMed ID: 22865631
[TBL] [Abstract][Full Text] [Related]
19. Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias.
Juric D; Lacayo NJ; Ramsey MC; Racevskis J; Wiernik PH; Rowe JM; Goldstone AH; O'Dwyer PJ; Paietta E; Sikic BI
J Clin Oncol; 2007 Apr; 25(11):1341-9. PubMed ID: 17312329
[TBL] [Abstract][Full Text] [Related]
20. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
